| | | |

Korean Cancer Doctors Embrace PIPAC for Mesothelioma

PIPAC for mesotheliomaFive out of ten Korean oncologists surveyed feel positive about using an aerosolized chemotherapy system called PIPAC for mesothelioma and other types of cancer.

PIPAC stands for pressurized intraperitoneal aerosol chemotherapy. The system turns liquid chemotherapy drugs into a spray that can be applied with a nebulizer. It was developed to treat surface malignancies like peritoneal mesothelioma that can be hard to treat with standard methods. 

PIPAC can be used in conjunction with mesothelioma surgery or by itself as either a palliative or curative treatment. 

The technology is still very new. Many doctors have never used it. But research conducted by the Seoul National University College of Medicine shows Korean doctors are ready to embrace it.

How Spray-on Chemotherapy Works

Mesothelioma cells are notoriously difficult to kill. The idea behind both HIPEC and PIPAC for mesothelioma is to deliver cancer-killing drugs directly to the tumor site. This precise delivery helps to minimize side effects. 

HIPEC stands for heated intraperitoneal chemotherapy. With HIPEC, doctors rinse heated drugs through a patient’s abdomen immediately after cytoreductive surgery (CRS). For patients who are good candidates, the CRS/HIPEC technique appears to offer the best odds of mesothelioma survival. 

PIPAC is similar but may offer more flexibility. With PIPAC, surgeons insert a spraying device called a nebulizer into the abdomen through an incision. Using an internal camera for guidance, they spray a cocktail of chemotherapy drugs onto the membrane where peritoneal mesothelioma tumors grow. 

If a peritoneal tumor is too large or widespread for CRS/HIPEC, PIPAC may function as a sort of bridge to surgery. One French study found that PIPAC for mesothelioma may increase the chances of being able to remove a tumor completely. 

PIPAC can also be used curatively. In a 2018 European study of mesothelioma patients who had more than two PIPAC treatments, 75 percent experienced some tumor regression. Ten percent of those patients had complete regression. Median overall survival was 26.6 months. 

High Acceptance and High Hopes for PIPAC for Mesothelioma 

Not all doctors are quick to embrace new technology. But the new study in Anticancer Research suggests that many Korean doctors are ready for PIPAC for mesothelioma and other cancers. 

Researchers sent a 20-question survey to 164 cancer doctors. Some of these doctors were mesothelioma specialists. Others focused on other kinds of cancer. 

Among the doctors who treat mesothelioma, ovarian cancer, or pseudomyxoma peritonei, 41.7 – 50 percent preferred PIPAC as a curative treatment. Among colorectal and hepatobiliary specialists, 32.7 – 33.3 percent chose PIPAC for palliative treatment of recurrent cancer. 

“Furthermore, 66.7-95.2% considered PIPAC appropriate for the cancers they specialized in, and 76-78.7% expected a treatment response of more than 50%,” reports study author Eun Ji Lee. These doctors indicated that they were OK with some low-grade complications from the treatment.

PIPAC for mesothelioma was developed in Germany and is being pioneered in Europe. It is not yet widely available in the US. Surgeons at the Mayo Clinic in Jacksonville, Florida performed the first US PIPAC procedure in December, 2019.

Source: 

Eun, JL, et al, “The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study”, January 2022, Anticancer Research, https://ar.iiarjournals.org/content/42/1/363

Nazario, Brunila, “Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC)”, June 18, 2020, WebMD, https://www.webmd.com/cancer/what-is-pipac

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…